Produkty 153-00-4

CAS 153-00-4 występuje w naszej ofercie pod nazwami: Methenolone (1.0mg/ml in Acetonitrile), Methenolone, >95% (HPLC), Methenolone, Methenolone 1.0 mg/ml in Acetonitrile. Oferty producentów: TRC, Mikromol, LoGiCal, Dr. Ehrenstorfer, Biosynth. Dostępne opakowania: 10x1ml, 100mg, 10mg, 50mg, 1ml.

Methenolone (1.0mg/ml in Acetonitrile)
TRC
  • opakowanie: 10x1ml
  • Warianty: 1
Zobacz produkt
Methenolone, >95% (HPLC)
TRC
  • opakowanie: 100mg, 10mg
  • Warianty: 2
Zobacz produkt
Methenolone
Mikromol, LoGiCal, Dr. Ehrenstorfer
  • opakowanie: 100mg, 10mg, 50mg
  • Warianty: 4
Zobacz produkt
Methenolone 1.0 mg/ml in Acetonitrile
LoGiCal
  • opakowanie: 1ml
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 153-00-4) to związek chemiczny o wzorze sumarycznym C20H30O2 i masie molowej 302.5 g/mol. Nazwa systematyczna IUPAC: (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: ANJQEDFWRSLVBR-VHUDCFPWSA-N.

Dane identyfikacyjne
Wzór sumarycznyC20H30O2
Masa molowa302.5 g/mol
Nazwa IUPAC(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyANJQEDFWRSLVBR-VHUDCFPWSA-N
SMILESCC1=CC(=O)C[C@H]2[C@]1([C@H]3CC[C@]4([C@H]([C@@H]3CC2)CC[C@@H]4O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: METHENOLONE, Metenolone, Metenolonum, Metenolona, Androst-1-en-3-one, 17-hydroxy-1-methyl-, (5alpha,17beta)-, 17beta-Hydroxy-1beta-methyl-5alpha-androst-1-en-3-one, Metenolone (INN), 17beta-Hydroxy-1-methyl-5alpha-androst-1-en-3-one, METENOLONE [INN], Metenolonum [INN-Latin]
Izomery (ten sam wzór sumaryczny)
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid C20H30O2
(3R,5R,8R,9R,10S,13S,14S,17R)-17-ethynyl-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C20H30O2
(1S,4S,5R,9S,10R,13R)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid C20H30O2
13-ethyl-3-methoxy-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-16-ol C20H30O2
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl)nona-2,4,6,8-tetraen-1-ol C20H30O2
(1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid C20H30O2
(8R,9S,10R,13S,14S,17S)-17-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one C20H30O2
(8R,9S,13S,14S,17S)-13-ethyl-3-methoxy-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-ol C20H30O2
(3S,5S,8R,9R,10S,13S,14S,17R)-17-ethynyl-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C20H30O2
(3R,5S,8R,9R,10S,13S,14S,17R)-17-ethynyl-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C20H30O2
4-[(1E,3E,5E,7E)-9-hydroxy-3,7-dimethylnona-1,3,5,7-tetraenyl]-3,5,5-trimethylcyclohex-3-en-1-ol C20H30O2
(5Z,8Z,11Z,14Z,17Z)-19,19,20,20,20-pentadeuterioicosa-5,8,11,14,17-pentaenoic acid C20H30O2